Martin Brejcha

532 total citations
24 papers, 327 citations indexed

About

Martin Brejcha is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Martin Brejcha has authored 24 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 7 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Martin Brejcha's work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Martin Brejcha is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Martin Brejcha collaborates with scholars based in Czechia, United States and Sweden. Martin Brejcha's co-authors include Z Smahel, Šárka Pospı́šilová, Jitka Malčíková, Jiřı́ Mayer, Michael Doubek, Yvona Brychtová, Jana Šmardová, Petr Kuglík, Martin Klabusay and Vladimíra Vranová and has published in prestigious journals such as Blood, Plastic & Reconstructive Surgery and British Journal of Haematology.

In The Last Decade

Martin Brejcha

17 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Brejcha Czechia 7 224 161 115 85 66 24 327
Kimberly J. Stockero United States 9 285 1.3× 223 1.4× 160 1.4× 59 0.7× 90 1.4× 9 390
Vladimíra Vranová Czechia 7 206 0.9× 115 0.7× 80 0.7× 40 0.5× 88 1.3× 16 290
Jade Forster United Kingdom 7 223 1.0× 185 1.1× 107 0.9× 17 0.2× 114 1.7× 13 320
S H Swerdlow United States 6 171 0.8× 283 1.8× 72 0.6× 30 0.4× 103 1.6× 8 412
Ellis G. Levine United States 6 266 1.2× 344 2.1× 75 0.7× 74 0.9× 59 0.9× 7 491
BM Wilkes United States 6 186 0.8× 244 1.5× 203 1.8× 23 0.3× 51 0.8× 8 410
Panagiotis Baliakas Sweden 11 312 1.4× 224 1.4× 156 1.4× 33 0.4× 113 1.7× 34 443
Dolors Sánchez-Izquierdo Spain 10 77 0.3× 160 1.0× 200 1.7× 54 0.6× 232 3.5× 15 585
M E Williams United States 7 190 0.8× 325 2.0× 58 0.5× 27 0.3× 102 1.5× 8 431
Elisa Tammiso Italy 12 332 1.5× 261 1.6× 203 1.8× 32 0.4× 71 1.1× 18 410

Countries citing papers authored by Martin Brejcha

Since Specialization
Citations

This map shows the geographic impact of Martin Brejcha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Brejcha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Brejcha more than expected).

Fields of papers citing papers by Martin Brejcha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Brejcha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Brejcha. The network helps show where Martin Brejcha may publish in the future.

Co-authorship network of co-authors of Martin Brejcha

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Brejcha. A scholar is included among the top collaborators of Martin Brejcha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Brejcha. Martin Brejcha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smolej, Lukáš, Martin Špaček, Šárka Pospı́šilová, et al.. (2021). Recommendations for chronic lymphocytic leukaemia dia gnosis and therapy 2021. 27(1). 91–106. 1 indexed citations
2.
3.
Smolej, Lukáš, Zuzana Kubová, Jana Mihályová, et al.. (2020). External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score. British Journal of Haematology. 193(1). 133–137. 4 indexed citations
4.
5.
Baliakas, Panagiotis, Michalis Iskas, Anne Gardiner, et al.. (2013). Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data. American Journal of Hematology. 89(3). 249–255. 73 indexed citations
6.
Adam, Zdeněk, Zdeněk Řehák, Marta Krejčí, et al.. (2012). [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].. PubMed. 58(1). 62–71. 2 indexed citations
7.
Ráčil, Zdeněk, Lucie Burešová, Martin Brejcha, et al.. (2011). Clinical and laboratory features of leukemias at the time of diagnosis: An analysis of 1,004 consecutive patients. American Journal of Hematology. 86(9). 800–803. 1 indexed citations
8.
Doubek, Michael, Jiřı́ Mayer, Petra Obrtlíková, et al.. (2011). Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice. European Journal Of Haematology. 87(2). 130–137. 13 indexed citations
9.
Doubek, Michael, Martin Brejcha, Zdeněk Pospı́šil, et al.. (2009). New prognostic markers of chronic lymphocytic leukemia in theeveryday hematological practice. A multicenter analysis.. 94.
10.
Doubek, Michael, Alexandra Jungová, Martin Brejcha, et al.. (2009). [Alemtuzumab in chronic lymphocytic leukemia treatment: retrospective analysis of outcome according to cytogenetics].. PubMed. 55(6). 549–54. 1 indexed citations
11.
Brejcha, Martin, et al.. (2009). [Preparation of patients on anticoagulant treatment for invasive surgery].. PubMed. 55(3). 272–5. 1 indexed citations
12.
Gumulec, Jaromír, et al.. (2006). [Prevention of venous thromboembolism: generally accepted guidelines].. PubMed. 52 Suppl 1. 6–16. 1 indexed citations
13.
Keßler, P., et al.. (2006). [Hemorrhagic complications during warfarin treatment].. PubMed. 52 Suppl 1. 79–91. 2 indexed citations
14.
Smahel, Z, Martin Brejcha, & Z Müllerová. (1991). Craniofacial morphology in unilateral cleft lip and palate in adults.. PubMed. 33(4). 224–41. 10 indexed citations
15.
Keßler, P., et al.. (1989). Bleeding complications of anticoagulant therapy. Reactions. 248(1). 2–2. 1 indexed citations
16.
Smahel, Z & Martin Brejcha. (1983). Differences in craniofacial morphology between complete and incomplete unilateral cleft lip and palate in adults.. PubMed. 20(2). 113–27. 57 indexed citations
17.
Fara, Michael, et al.. (1971). Neurofibromatosis of the head. Plastic & Reconstructive Surgery. 48(5). 517–517. 7 indexed citations
18.
Brejcha, Martin, et al.. (1967). [Radiographic diagnosis of functional disorders of the temporomandibular joint in Costen's syndrome].. PubMed. 106(16). 413–6.
19.
Brejcha, Martin, et al.. (1963). [BONE CHANGES IN RECKLINGHAUSEN'S NEUROFIBROMATOSIS].. PubMed. 30. 484–9. 2 indexed citations
20.
Brejcha, Martin, et al.. (1963). [CHANGES IN THE MAXILLARY SINUSES FOLLOWING THE CALDWELL-LUC OPERATION].. PubMed. 9. 225–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly J. Stockero Breakdown of academic impact, for papers by Vladimíra Vranová Breakdown of academic impact, for papers by Jade Forster Breakdown of academic impact, for papers by S H Swerdlow Breakdown of academic impact, for papers by Ellis G. Levine Breakdown of academic impact, for papers by BM Wilkes Breakdown of academic impact, for papers by Panagiotis Baliakas Breakdown of academic impact, for papers by Dolors Sánchez-Izquierdo Breakdown of academic impact, for papers by M E Williams Breakdown of academic impact, for papers by Elisa Tammiso
Rankless by CCL
2026